Table 2.
Cross‐neutralization test with TW‐I, TW‐II, Mass‐type strains and three IBV recombinant variants
| IBV strain | 2575/98 (TW‐I) | 2296/95 (TW‐II) | H120 (Mass) | S78/14 (TW–JP) | 2992/02 (TW–CN) | 3382/06 (TW‐Mass) |
|---|---|---|---|---|---|---|
| 2575/98 (TW‐I) | 100 | |||||
| 2296/95 (TW‐II) | 12.0 | 100 | ||||
| H120 (Mass) | 2.6 | 12.8 | 100 | |||
| S78/14 (TW–JP) | 0.9 | 1.0 | 1.5 | 100 | ||
| 2992/02 (TW–CN) | 1.2 | 4.3 | 5.0 | 1.0 | 100 | |
| 3382/06 (TW‐Mass) | 68.5 | 2.6 | 2.1 | 0.6 | 2.0 | 100 |
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.